Öz

Objective: Invasive pneumococcal disease (IPD) is a rare but serious cause of neonatal sepsis associated with significant morbidity and mortality. Despite widespread pneumococcal conjugate vaccine (PCV) use in infants, neonates remain vulnerable due to lack of direct vaccination and potential vertical or horizontal transmission. This study aimed to characterize the clinical, laboratory, and microbiological features of neonatal IPD and to evaluate associated outcomes in this high-risk population.

Material and Methods: We conducted a retrospective cross-sectional study of neonates (0–30 days old) diagnosed with IPD between September 2019 and April 2025. Diagnosis was confirmed by isolation of Streptococcus pneumoniae from sterile body fluids or PCR detection. Demographic, clinical, microbiological, and outcome data were analyzed.

Results: Among 68 IPD cases, 12 neonates with pneumococcal bacteremia were identified; no meningitis or focal infections were observed. The cohort had equal sex distribution, mean gestational age of 35±3.8 weeks, and 33.3% had comorbidities. Early-onset sepsis (≤72 hours) accounted for 25% of cases, with the remainder presenting as late-onset sepsis (>72 hours). One neonate had concurrent SARS-CoV-2 infection. All patients survived; one preterm infant developed neurological sequelae attributable to pre-existing conditions. Antibiotic susceptibility testing showed reduced sensitivity to penicillin (20%) and ceftriaxone (16.7%), while vancomycin and linezolid remained highly effective.

Conclusion: Neonatal invasive pneumococcal bacteremia, although uncommon, continues to pose clinical challenges, particularly due to evolving antimicrobial resistance. Our findings emphasize the importance of vigilant clinical monitoring and tailored antimicrobial therapy in this vulnerable population. Continued surveillance and prospective studies are warranted to assess the impact of maternal and early infant vaccination strategies on neonatal IPD prevention.

Anahtar Kelimeler: Antibiotic resistance, bacteremia, pneumococcal infections, sepsis, Streptococcus pneumoniae

Kaynakça

  1. von Mollendorf C, Tempia S, von Gottberg A, Meiring S, Quan V, Feldman C, et al. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLoS One. 2017;12(7):e0179905. https://doi.org/10.1371/journal.pone.0179905
  2. Olarte L, AK. Streptococcus pneumoniae. In: In S. S. Long CGP& MF (Eds. ), editor. Principles and practice of pediatric infectious diseases. 6th ed. 2023. https://doi.org/10.1016/B978-0-323-75608-2.00123-3
  3. Şimşek Orhon F. Genişletilmiş Bağışıklama Programına Her Yönüyle Bakış. Osmangazi Journal Of Medicine. 2020;6-14. https://doi.org/10.20515/otd.681563
  4. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine. JAMA. 2006;295(14):1668. https://doi.org/10.1001/jama.295.14.1668
  5. Ladhani SN, Andrews NJ, Waight P, Borrow R, Slack MPE, Miller E. Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales. Clinical Infectious Diseases. 2013;56(5):633-40. https://doi.org/10.1093/cid/cis934
  6. Alan S, Yıldız D, Erdeve Ö, Atasay B, Nar Otgun S, İnc E, et al. An Early Neonatal Sepsis Case Due to Streptococcus pneumoniae Serotype 7F. Mikrobiyol Bul. 2013;158-63. https://doi.org/10.5578/mb.4237
  7. Malhotra A, Hunt RW, Doherty RR. Streptococcus pneumoniae sepsis in the newborn. J Paediatr Child Health. 2012;48(2). https://doi.org/10.1111/j.1440-1754.2010.01929.x
  8. Hoffman JA, Mason EO, Schutze GE, Tan TQ, Barson WJ, Givner LB, et al. Streptococcus pneumoniae Infections in the Neonate. Pediatrics. 2003;112(5):1095-102. https://doi.org/10.1542/peds.112.5.1095
  9. Kaplan M, Rudensky B, Beck A. Perinatal Infections with Streptococcus Pneumoniae. Am J Perinatol. 1993;10(01):1-4. https://doi.org/10.1055/s-2007-994687
  10. Sallam A, Paes B. Streptococcus pneumoniae: An Old Bug with Significant Maternal-Newborn Implications. Am J Perinatol. 2004 Nov;21(08):491-5. https://doi.org/10.1055/s-2004-835967
  11. Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. The Lancet. 2017;390(10104):1770-80.https://doi.org/10.1016/S0140-6736(17)31002-4
  12. Puopolo KM, Benitz WE, Zaoutis TE, Cummings J, Juul S, Hand I, et al. Management of Neonates Born at ≤34 6/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2018;142(6). https://doi.org/10.1542/peds.2018-2896
  13. Gomez M, Alter S, Kumar M Lou, Murphy S, Rathore MH. Neonatal Streptococcus pneumoniae infection: case reports and review of the literature. Pediatr Infect Dis J. 1999 ;18(11):1014-8. https://doi.org/10.1097/00006454-199911000-00016
  14. Moodley K, Coovadia YM, Cohen C, Meiring S, Lengana S, De Gouveia L, et al. Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008. Pediatric Infectious Disease Journal. 2019;38(4):424-30. https://doi.org/10.1097/INF.0000000000002096
  15. Bortolussi R, Thompson TR, Ferrieri P. Early-onset pneumococcal sepsis in newborn infants. Pediatrics. 1977;60(3):352-5. https://doi.org/10.1542/peds.60.3.352
  16. Meropol SB, Jacobs MR, Stange KC, Bajaksouzian S, Bonomo RA. Longitudinal Colonization With Streptococcus pneumoniae During the First Year of Life in a Healthy Newborn Cohort. J Pediatric Infect Dis Soc. 2020;9(4):442-8. https://doi.org/10.1093/jpids/piz068
  17. Oeser C, Pond M, Butcher P, Bedford Russell A, Henneke P, Laing K, et al. PCR for the detection of pathogens in neonatal early onset sepsis. PLoS One. 2020;15(1):e0226817. https://doi.org/10.1371/journal.pone.0226817
  18. Coelho I, Baptista S, Ramalho AR, Calado C, Gaspar L, Virtuoso MJ, et al. Early-Onset Neonatal Pneumococcal Sepsis: An Old but Sometimes Forgotten Pathogen. Cureus. 2022 Sep 21;https://doi.org/10.7759/cureus.29403
  19. Hermoso Torregrosa C, Carrasco Zalvide M, Ferrer Castillo MT. Streptococcus pneumoniae: un patógeno poco habitual en la sepsis neonatal de transmisión vertical. Arch Bronconeumol. 2012;48(11):425-6.https://doi.org/10.1016/j.arbres.2012.03.010
  20. Amin-Chowdhury Z, Bertran M, Abdullahi F, Sheppard CL, Eletu SD, Litt DJ, et al. Risk of invasive pneumococcal disease during pregnancy and postpartum and association with adverse maternal and foetal outcomes: A prospective cohort study, England, 2014-19. Journal of Infection. 2025;90(1):106363.https://doi.org/10.1016/j.jinf.2024.106363
  21. Hascelik G, Sancak B, Kasikci M. A twenty years’ results of the antimicrobial resistance profile and multidrug resistance trend of invasive Streptococcus pneumoniae isolates recovered from adult patients in Turkey: A literature review. Indian J Med Microbiol. 2022 ;40(3):342-6. https://doi.org/10.1016/j.ijmmb.2022.06.004
  22. Maraki S, Mavromanolaki VE, Stafylaki D, Iliaki-Giannakoudaki E, Kasimati A, Hamilos G. Antimicrobial Resistance of Streptococcus pneumoniae Clinical Serotypes between 2017 and 2022 in Crete, Greece. Infect Chemother. 2024;56(1):73. https://doi.org/10.3947/ic.2023.0098
  23. Kozakova J, Krizova P, Maly M. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic. PLoS One. 2021 ;16(2):e0247862.https://doi.org/10.1371/journal.pone.0247862
  24. Yen TA, Wu JL, Wang CC, Huang LY, Yeo SH, Patel D, et al. A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015. BMC Infect Dis. 2025;25(1):176. https://doi.org/10.1186/s12879-024-10379-z
  25. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. The Lancet. 2009;374(9693):893-902. https://doi.org/10.1016/S0140-6736(09)61204-6
  26. Chaithongwongwatthana S, Yamasmit W, Limpongsanurak S, Lumbiganon P, Tolosa JE. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database of Systematic Reviews. 2015;2015(1). https://doi.org/10.1002/14651858.CD004903.pub4

Telif hakkı ve lisans

Telif hakkı © 2025 Yazar(lar). Açık erişimli bu makale, orijinal çalışmaya uygun şekilde atıfta bulunulması koşuluyla, herhangi bir ortamda veya formatta sınırsız kullanım, dağıtım ve çoğaltmaya izin veren Creative Commons Atıf Lisansı (CC BY) altında dağıtılmıştır.

Nasıl atıf yapılır

1.
Demirci B, Bayhan Gİ, Erat T, Yahşi A, Özen S, Baş AY, et al. Clinical characteristics and outcomes of invasive pneumococcal disease in neonates: A retrospective study. Turk J Pediatr Dis. 2026;20(1):58-63. https://doi.org/10.12956/TJPD.2025.1217